Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3290940 | 0.92 | ALDH1A1 (0.44) | EPHX1TP53CYP3A4TSHRALDH1A1 | |
| SCHEMBL31505787 | 0.90 | TP53 (0.44) | TP53CYP3A4TSHRALDH1A1NAAA | |
| SCHEMBL6409819 | 0.84 | EPHX1 (0.52) | EPHX1TP53CYP3A4ALDH1A1POLB | |
| SCHEMBL18729773 | 0.84 | TSHR (0.45) | EPHX1TSHRNAAA | |
| SCHEMBL22534528 | 0.84 | TSHR (0.45) | EPHX1TSHRNAAA | |
| SCHEMBL9910594 | 0.84 | TSHR (0.45) | EPHX1TSHRNAAA | |
| SCHEMBL3412445 | 0.83 | EPHX1 (0.47) | EPHX1TP53CYP3A4ALDH1A1NAAA | |
| SCHEMBL3289323 | 0.83 | EPHX1 (0.47) | EPHX1TP53CYP3A4ALDH1A1NAAA | |
| SCHEMBL12894434 | 0.83 | EPHX1 (0.50) | EPHX1TP53CYP3A4ALDH1A1THRB | |
| SCHEMBL13104104 | 0.83 | EPHX1 (0.50) | EPHX1TP53CYP3A4ALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090131301-A1 | METHYL CYCLOHEXANE CARBOXYLATES AND THEIR USE IN PERFUME COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131301-A1 | METHYL CYCLOHEXANE CARBOXYLATES AND THEIR USE IN PERFUME COMPOSITIONS | C5, OR51E2, OXER1 | EPHX1 565/4885TP53 2045/4885CYP3A4 288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.